Expert second opinions for hypertrophic cardiomyopathy. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Hypertrophic Cardiomyopathy (HCM) is the most common genetic cardiovascular disease, characterized by abnormal thickening of the heart muscle. If you are facing a decision about hypertrophic cardiomyopathy, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, characterized by abnormal thickening of the heart muscle. Left ventricular outflow tract (LVOT) obstruction occurs in approximately two-thirds of patients and is the primary target of surgical intervention.
HCM management is highly specialized. Septal myectomy at an experienced center has mortality under 1% and provides durable symptom relief, yet many patients are offered alcohol septal ablation or managed medically without referral to an HCM center. The decision between myectomy and ablation, ICD placement for sudden death prevention, and genetic counseling all benefit from expert evaluation.
Surgery for hypertrophic cardiomyopathy depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. HCM management is highly specialized. Septal myectomy at an experienced center has mortality under 1% and provides durable symptom relief, yet many patients are offered alcohol septal ablation or managed medically without referral to an HCM center. The decision between myectomy and ablation, ICD placement for sudden death prevention, and genetic counseling all benefit from expert evaluation.
Operative mortality for hypertrophic cardiomyopathy-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for hypertrophic cardiomyopathy depends on anatomy, comorbidities, age, and personal goals. Septal myectomy vs alcohol septal ablation. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.